Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Non-interventional, Observational Study to Evaluate Common Therapeutic Algorithms and Possible Predictive Parameters for Somatuline Autogel® (ATG) Treatment in Subjects With Either Acromegaly or Neuroendocrine Tumours (NET)

NCT01840449 is registered in ClinicalTrials.gov with Ipsen as lead sponsor.

NCT NCT01840449
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01840449 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Non-interventional, Observational Study to Evaluate Common Therapeutic Algorithms and Possible Predictive Parameters for Somatuline Autogel® (ATG) Treatment in Subjects With Either Acromegaly or Neuroendocrine Tumours (NET)
Lead sponsor
Ipsen
Phase
Observational
Overall status
Completed
Start date
June 30, 2012
Completion date
May 31, 2017
Enrollment
156 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

acromegaly, neuroendocrine tumours